Study Name Principal Investigator
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma McDonough, Colleen
(HLA-G) To Develop and Optimize Innovative Methods and Therapies that Prevent Rejection and Prolong Transplant Survival in Patients Mulloy, Laura
(In vitro D-dimer) The Diagnostic Utility of the in-vitro Provoked D dimer test in patients with suspected thromboembolism, either pulmonary embolism (PE) or deep venous thrombosis (DVT) or both Robinson, Vincent
An Objective Tool to Aid Diagnosis of PTSD and Evaluate Treatment outcome Vazdarjanova, Almira
EA1131 A Randomized Phase III Post Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy Ghamande, Sharad
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma McDonough, Colleen
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG Johnson, Theodore
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Kota, Vamsi
Psychological Flexibility and Changes in Functioning in an Acceptance and Commitment Therapy Group for Stage 2 DBT Patients House, Amy
The Effect of Low Frequency Soundwave Stimulation on Chemotherapy Induced Peripheral Neuropathy Johnson, Marian
RESEARCH. INNOVATION. DISCOVERY.
Augusta University
Research
AU Health
Stay Informed
Get updates on new trials and more
(706)721-6582 © Augusta University 1120 15th Street Augusta, GA 30912